*The following content is generated by AI and is for reference only.
Fmoc-D-Homoallylglycine is a specialized F-protected amino acid derivative widely utilized in modern peptide synthesis and medicinal chemistry. With the chemical formula C17H21NO4 and CAS Registry Number 135690-89-5, this compound serves as a critical building block for constructing complex peptidomimetics and bioactive peptides. The molecule features a fluorenylmethyloxycarbonyl (Fmoc) protecting group attached to the N-terminus of D-homoallylglycine, ensuring stability during solid-phase peptide synthesis (SPPS) while allowing for selective deprotection under mild basic conditions.
The structural backbone incorporates an extended carbon chain compared to standard glycine, introducing a homoallyl side chain that provides unique spatial properties and conformational flexibility. This specific configuration makes Fmoc-D-Homoallylglycine invaluable for researchers aiming to modulate peptide pharmacokinetics, enhance metabolic stability, or introduce non-natural stereochemistry into therapeutic candidates. The D-enantiomer is particularly sought after in drug development to resist enzymatic degradation by proteases, which typically target L-amino acids, thereby extending the half-life of peptide-based therapeutics.
Primary applications include the synthesis of cyclic peptides, stapled helices, and macrocyclic structures where the allyl moiety offers a convenient handle for further functionalization via olefin metathesis or thiol-ene click chemistry. Researchers frequently employ this reagent to create libraries of compounds for high-throughput screening in oncology, infectious diseases, and autoimmune disorders. Its compatibility with standard Fmoc-SPPS protocols ensures seamless integration into existing laboratory workflows without requiring specialized equipment. Furthermore, the homoallyl group facilitates post-synthetic modifications, enabling the attachment of fluorophores, biotin tags, or other reporter molecules for biological studies. As a high-purity reagent, it supports rigorous academic research and industrial pharmaceutical manufacturing, contributing significantly to the advancement of next-generation peptide drugs and diagnostic agents.